| modeling hiv transmission risk among mozambicans prior to their initiating highly active antiretroviral therapy. | understanding sexual behavior and assessing transmission risk among people living with hiv-1 is crucial for effective hiv-1 prevention. we describe sexual behavior among hiv-positive persons initiating highly active antiretroviral therapy (haart) in beira, mozambique. we present a bernoulli process model (tool available online) to estimate the number of sexual partners who would acquire hiv-1 as a consequence of sexual contact with study participants within the prior three months. baseline data ... | 2007 | 17505919 |
| genetic characterization of human immunodeficiency virus type 1 from beira, mozambique. | in this report, we examined the genetic diversity of hiv-1 strains circulating in the city of beira, the second largest metropolitan area in mozambique. a total of 131 blood samples, collected between august and october 2003 from antiretroviral-naïve individuals, were characterized with a combined approach consisting of heteroduplex mobility assay (hma) subtyping for gag (n=74) and/or env (n=117) genes, and dna sequence analysis of proviral env (c2v3c3, n=52), ltr (n=30) and/or pol (n=43) genomi ... | 2006 | 16849040 |
| comparison of the diagnostic accuracy of a rapid immunochromatographic test and the rapid plasma reagin test for antenatal syphilis screening in mozambique. | programmes to control syphilis in developing countries are hampered by a lack of laboratory services, delayed diagnosis, and doubts about current screening methods. we aimed to compare the diagnostic accuracy of an immunochromatographic strip (ics) test and the rapid plasma reagin (rpr) test with the combined gold standard (rpr, treponema pallidum haemagglutination assay and direct immunofluorescence stain done at a reference laboratory) for the detection of syphilis in pregnancy. | 2006 | 16501726 |
| effectiveness of mass oral cholera vaccination in beira, mozambique. | new-generation, orally administered cholera vaccines offer the promise of improved control of cholera in sub-saharan africa. however, the high prevalence of human immunodeficiency virus (hiv) infection in many cholera-affected african populations has raised doubts about the level of protection possible with vaccination. we evaluated a mass immunization program with recombinant cholera-toxin b subunit, killed whole-cell (rbs-wc) oral cholera vaccine in beira, mozambique, a city where the seroprev ... | 2005 | 15728808 |
| [aids: is it a risk factor in cerebrovascular disease?]. | cerebrovascular disease (cvd) has become an important health problem throughout the world. it is generally one the main causes of morbidity and mortality in the world, especially in developed countries. in these countries the frequency with which it appears is linked with the progress reached in the organisation of the public health system and the higher economic and social standards of their populations, which have given rise to prolonged life expectancy and a greater number of elderly people. ... | 2002 | 12436376 |